Advances in Medications:

Over the past ten years the greatest advances in ADHD medicines have not been the development of some wonder drug, though some good medications have been developed. Rather the most important advances in ADHD medications have been the with the improvement of, and greater variety of the delivery systems of the time tested drugs for ADHD.

Because of these recent advances, the time tested methylphenidate comes in four different delivery forms: Read more of the article...

• Pills
• Pumps
• Pellets
• Patches

Ritalin and Adderall may be in Short Supply for the Summer of 2011

Have you experienced problems in filling your prescriptions for your ADHD medications such as Ritalin or Adderall?

Recently the FDA had to add some common ADHD medications to their list of drugs that are in short supply across the country, and many parents are reporting difficulty in finding a pharmacy that can fill their prescriptions. Read more of the article...

Once-Daily Vyvanse approved for the treatment of ADHD in children and adults, and now in adolescents

PHILADELPHIA – November 15, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms compared to placebo in adolescents with ADHD.1 Vyvanse is also indicated for the treatment of ADHD in children ages 6 to 12 years, and adults.1 Read more of the article...

Ending Guesswork In Prescribing ADHD Drug
05 May 2010

Children with ADHD who carry a specific type of dopamine receptor gene respond better to the drug methylphenidate (MPH) than those without the genotype, according to new research from Cincinnati Children's Hospital Medical Center. Read more of the article...

DrugWatch.com is a comprehensive Web site containing information about many medications, including common prescriptions and over-the-counter drugs available worldwide. The Web site features an A-Z index of the medications, making it easy for patients to find information about specific drugs, such as Adderall, Ritalin, Vyvanse, and Concerta, which are commonly used to treat ADD and ADHD. Read more of the article...

Early Reports on Intuniv for ADHD

Intuniv is a new medication for the treatment of ADHD in children and teens that just recently gained its approval from the FDA and was available to pharmacies in early November, 2009.

Intuniv is not a stimulant medication, and may be helpful to the estimated 25-30% of children with ADHD who do not benefit from stimulant medications. Instead, Intuniv is a form of Guanfacine (Tenex) which has been used for years as a blood pressure medication in adults, and has also been used as an adjunct medication in the treatment of ADHD individuals with temper or anger problems, or oppositional defiant disorder. Now in the form of Intuniv, this medication seems to have a wider range of symptoms that benefit from its use than just anger or oppositional behavior.

It appears that Intuniv (guanfacine) works in the pre-frontal cortex Read more of the article...

What is INTUNIV for ADHD?

The active ingredient in INTUNIV is Guanfacine, normally thought of as the blood pressure medicine Tenex. INTUNIV is not a blood pressure medication, however. It is approved for the treatment of ADHD.

INTUNIV is not a stimulant, and its action on the brain is different than stimulants. INTUNIV is another ADHD medication from Shire Pharmaceuticals, where they seem to insist that all of their medications are spelled in all capital letters. Shire also makes and distributes ADDERALL XL, DAYTRANA, and VYVANSE. And since the sales of Adderall XR have been undercut by Teva's generic Adderall, and the sales of Vyvanse have been disappointing, Shire is hopeful that Intuniv will bolster its place in the ADHD marketplace. Read more of the article...

ADHD is a neurological disorder that impacts between 5% and 9% of children, teens, and even adults. Over the years, as more pharmaceutical companies enter the market, and more medications are developed, there has been a signficiant increase int he use of ADHD medications - and a recent study suggests an increase in the misuse of such medications. Read more of the article...

Intuniv TM and Vivanse

Shire Pharmaceuticals has invested heavily in developing medications for the treatment of ADHD in both children and adults. While Vivanse has become an option for many prescribing physicians and parents, they also have new medications “in the pipeline” to bring to the ADHD market. Read more of the article...